Nujol (Liquid Paraffin)

Liquid paraffin coats the contents of the gastrointestinal tract with a thin, water‑repellent layer. This barrier prevents water from being reabsorbed into the stool, keeping it soft and lubricated, which promotes easier and more comfortable bowel movements without stimulating intestinal muscle activity.

The appropriate dose of Nujol is determined by the prescribing healthcare professional based on the patient’s age, condition, and response to therapy. Dosage instructions are provided on the product label and should be followed as directed by the prescriber.

Liquid paraffin is generally considered low risk because it is minimally absorbed from the gastrointestinal tract. However, pregnant or breastfeeding individuals should consult their healthcare provider before using Nujol to ensure it is appropriate for their specific situation.

To order Nujol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike stimulant laxatives that increase intestinal motility, Nujol is a lubricant laxative that works by coating stool to retain moisture. This mechanism results in softer stools with fewer cramping side effects, making it suitable for patients who need gentle relief or who cannot tolerate stimulant agents.

Nujol should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from direct sunlight, moisture, and heat, and store it in its original packaging to maintain product stability.

Nujol is taken orally as a liquid. The prescribed dose is measured using a calibrated spoon or syringe and swallowed directly or mixed with a small amount of water or food, as advised by the healthcare professional.

The most serious risks include aspiration pneumonia if the liquid is inhaled, lipid pneumonia from chronic aspiration, severe allergic reactions, and rare cases of intestinal obstruction. Patients should be monitored for these events, especially if they have swallowing difficulties.

Nujol should be avoided in individuals with known hypersensitivity to mineral oil, those with suspected or confirmed bowel obstruction, patients with severe dysphagia, and anyone who has experienced aspiration of oil‑based products in the past.